The Impact of ALS-Associated Genes hnRNPA1, MATR3, VCP and UBQLN2 on the Severity of TDP-43 Aggregation
Open accessThe DOI matches its Crossref record; 93 of the 94 references it cites were found in a registry or an index.
Abstract
Amyotrophic lateral sclerosis is a progressive neurodegenerative disorder, characterized by cytoplasmic inclusions of RNA-binding protein TDP-43. Despite decades of research and identification of more than 50 genes associated with amyotrophic lateral sclerosis (ALS), the cause of TDP-43 translocation from the nucleus and its aggregation in the cytoplasm still remains unknown. Our study addressed the impact of selected ALS-associated genes on TDP-43 aggregation behavior in wild-type and aggregation prone TDP-43 in vitro cell models. These were developed by deleting TDP-43 nuclear localization signal and stepwise shortening its low-complexity region. The SH-SY5Y cells were co-transfected with the constructs of aggregation-prone TDP-43 and wild-type or mutant ALS-associated genes hnRNPA1, MATR3, VCP or UBQLN2. The investigated genes displayed a unique impact on TDP-43 aggregation, generating distinct types of cytoplasmic inclusions, similar to those already described as resembling prion strains, which could represent the basis for neurodegenerative disease heterogeneity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Unfortunately, modelling MND for drug discovery purposes remains challenging, partly due to the range of pathological mechanisms implicated, many of which are backed by genetic associations5–10.”
From Examining iPSC derived motor neuron variability and genome stability monitoring as a solution (2025) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576 · cited 1×
“The main component of these inclusions represents ubiquitinated, phosphorylated and cleaved TAR DNA-binding protein 43 (TDP-43) [1].”
BackgroundMolliex, A., Temirov, J., Lee, J., Coughlin, M., Kanagaraj, A. P., Kim, H. J., Mittag, T., & Taylor, J. P. (2015) · Cell · doi:10.1016/j.cell.2015.09.015 · Cited by 2,893
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630
Self-citationMutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Vance, C., Rogelj, B., Hortobágyi, T., De Vos, K. J., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P., et al. (2009) · Science · doi:10.1126/science.1165942 · Cited by 2,564
Self-citationVisualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression
Sakaue-Sawano, A., Kurokawa, H., Morimura, T., Hanyu, A., Hama, H., Osawa, H., Kashiwagi, S., Fukami, K., Miyata, T., Miyoshi, H., et al. (2008) · Cell · doi:10.1016/j.cell.2007.12.033 · Cited by 2,173
Decoding ALS: from genes to mechanism
Taylor, J. P., Brown, R. H., & Cleveland, D. W. (2016) · Nature · doi:10.1038/nature20413 · Cited by 2,066
Formation and Maturation of Phase-Separated Liquid Droplets by RNA-Binding Proteins
Lin, Y., Protter, D. S. W., Rosen, M. K., & Parker, R. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.08.018 · Cited by 1,585
Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS
Kim, H. J., Kim, N. C., Wang, Y.-D., Scarborough, E. A., Moore, J., Diaz, Z., MacLea, K. S., Freibaum, B., Li, S., Molliex, A., et al. (2013) · Nature · doi:10.1038/nature11922 · Cited by 1,475
Mutations of optineurin in amyotrophic lateral sclerosis
Maruyama, H., Morino, H., Ito, H., Izumi, Y., Kato, H., Watanabe, Y., Kinoshita, Y., Kamada, M., Nodera, H., Suzuki, H., et al. (2010) · Nature · doi:10.1038/nature08971 · Cited by 1,265
Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS
Johnson, J. O., Mandrioli, J., Benatar, M., Abramzon, Y., Van Deerlin, V. M., Trojanowski, J. Q., Gibbs, J. R., Brunetti, M., Gronka, S., Wuu, J., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.036 · Cited by 1,235
Cited by
Combating deleterious phase transitions in neurodegenerative disease
Darling, A. L., & Shorter, J. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.118984 · Cited by 85
Update on the Development of MNK Inhibitors as Therapeutic Agents
Xu, W., Kannan, S., Verma, C. S., & Nacro, K. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00368 · Cited by 66
Matrin 3 in neuromuscular disease: physiology and pathophysiology
Malik, A. M., & Barmada, S. J. (2021) · JCI Insight · doi:10.1172/jci.insight.143948 · Cited by 57
A system-wide mislocalization of RNA-binding proteins in motor neurons is a new feature of ALS
Liu, Y., Kuo, H., & Chern, Y. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105531 · Cited by 9
Different Chronic Stress Paradigms Converge on Endogenous TDP43 Cleavage and Aggregation
Candelise, N., Caissutti, D., Zenuni, H., Nesci, V., Scaricamazza, S., Salvatori, I., Spinello, Z., Mattei, V., Garofalo, T., Ferri, A., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03455-z · Cited by 8
Examining iPSC derived motor neuron variability and genome stability monitoring as a solution
Gaffey, F., McCoull, D., Vaitone, E., Hedges, E., Lovejoy, C., Yao, Z., Wright, P. D., Mead, R. J., & Stebbeds, W. (2025) · Scientific Reports · doi:10.1038/s41598-025-23378-0 · Cited by 4
1H, 13C and 15N resonance assignments and solution structures of the two RRM domains of Matrin-3
He, F., Kuwasako, K., Takizawa, M., Takahashi, M., Tsuda, K., Nagata, T., Watanabe, S., Tanaka, A., Kobayashi, N., Kigawa, T., et al. (2021) · Biomolecular NMR Assignments · doi:10.1007/s12104-021-10057-0 · Cited by 4
Role of Triggers on the Structural and Functional Facets of TAR DNA-binding Protein 43
Camilus, N. S., Arias, C. Q., & Martić, S. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.11.027 · Cited by 5
Ramzan, F., Mishra, G. G., Alshehabi, Y., Perry, C. M., Jadon, L. M. Q., Kumar, A., Kim, H., Uy, R. C., Dang, A., Fayyad, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.05.716148 · Cited by 3
Yang, C.-H., Huang, J.-L., Tsai, L., Taniar, D., & Pai, T. (2024) · Bioengineering · doi:10.3390/bioengineering11101020
hnRNPA1 orchestrates multi-layered regulation of SNCA expressionPreprint
Kattan, F.-G., Anagnostopoulos, A. K., Tsangaris, G. T., & Doxakis, E. (2025) · Research Square · doi:10.21203/rs.3.rs-6294566/v1
Comprendre et modéliser la Sclérose Latérale Amyotrophique à début précoce
Muratet, F. (2022) · theses.fr (ABES) · doi:10.70675/9a7778aaz88c7z40b1z92d3zaf5699b86a09 · Cited by 1
Neurodegenerative spliceosomopathies
Mavillonio, A., Rizzini, D., Detassis, S., & Denti, M. A. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1787859
Tripathi, P., Guo, H., Yamoah, A., Mathur, R., Doukas, P., Dreser, A., Jesse, C. M., Aronica, E., Hermann, A., Steinbusch, H. W. M., et al. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02298-8
Singh, N., & Gomes, J. (2026) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2026.117943
Tang, W. J., Sun, W., Xue, W., & Liu, X. (2026) · Research Square · doi:10.21203/rs.3.rs-10866091/v1
BindingDB Entry 50016838: Update on the Development of MNK Inhibitors as Therapeutic Agents.
BindingDB (2023) · UC San Diego · doi:10.7270/q20c50t2
Metadata
- Authors
- Bajc Česnik, A., Motaln, H., & Rogelj, B.
- Affiliations
- Department of Biotechnology, Jozef Stefan Institute, 1000 Ljubljana, Slovenia
- Jožef Stefan Institute (SI)
- University of Ljubljana (SI)
- Corresponding author
- Rogelj, Boris
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-07-28
- Volume
- 9
- Issue
- 8
- Pages
- 1791
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7465640
- OpenAlex
- W3045936106
- Cited by
- 17
- References
- 94
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 5
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Javna Agencija za Raziskovalno Dejavnost RS (P4-0127, J3-8201, N3-0141, J7-9399 and J3-9263)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Keywords
- amyotrophic lateral sclerosis, TDP-43 aggregation, hnRNP A1, MATR3, VCP, UBQLN2, low complexity regions, cytoplasmic inclusions, prion-like behavior, SH-SY5Y cells
- MeSH terms
- Autophagy-Related Proteins, Amyotrophic Lateral Sclerosis, DNA-Binding Proteins, Humans, Transfection, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.